Xylem Inc. $XYL Shares Sold by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 5.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 85,160 shares of the industrial products company’s stock after selling 4,722 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Xylem were worth $12,505,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. UniSuper Management Pty Ltd increased its position in shares of Xylem by 4.9% during the third quarter. UniSuper Management Pty Ltd now owns 124,376 shares of the industrial products company’s stock valued at $18,345,000 after acquiring an additional 5,842 shares during the last quarter. Hunter Associates Investment Management LLC purchased a new position in shares of Xylem during the 3rd quarter worth approximately $220,000. Westfuller Advisors LLC acquired a new stake in Xylem in the 3rd quarter valued at approximately $121,000. Teacher Retirement System of Texas raised its position in Xylem by 41.6% in the third quarter. Teacher Retirement System of Texas now owns 52,342 shares of the industrial products company’s stock valued at $7,720,000 after purchasing an additional 15,389 shares during the period. Finally, Northstar Asset Management Inc. lifted its stake in Xylem by 0.8% during the third quarter. Northstar Asset Management Inc. now owns 80,347 shares of the industrial products company’s stock worth $11,851,000 after purchasing an additional 667 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

XYL has been the subject of a number of research reports. Mizuho dropped their price objective on Xylem from $160.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, January 5th. Zacks Research downgraded Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. UBS Group increased their price target on shares of Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Xylem in a research note on Friday, December 5th. Eight analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $165.80.

Insider Buying and Selling at Xylem

In other Xylem news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is currently owned by insiders.

Xylem Stock Performance

Shares of Xylem stock opened at $141.06 on Monday. The business has a 50-day simple moving average of $139.66 and a 200-day simple moving average of $141.61. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. Xylem Inc. has a one year low of $100.47 and a one year high of $154.27. The company has a market cap of $34.34 billion, a PE ratio of 36.26, a P/E/G ratio of 2.00 and a beta of 1.17.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm had revenue of $2.27 billion for the quarter, compared to analysts’ expectations of $2.22 billion. During the same quarter last year, the company earned $1.11 earnings per share. The firm’s revenue was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities research analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is presently 41.13%.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.